Peter Sminia

Amsterdam, NH, Netherlands

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications

Challenges to determine synergistic drug interactions in mice.

Challenges to determine synergistic drug interactions in mice.

Journal: Nature communications
Published: November 10, 2023

Differential Sensitivity to Ionizing Radiation in Gemcitabine-Resistant and Paclitaxel-Resistant Pancreatic Cancer Cells.

Differential Sensitivity to Ionizing Radiation in Gemcitabine-Resistant and Paclitaxel-Resistant Pancreatic Cancer Cells.

Journal: International journal of radiation oncology, biology, physics
Published: June 02, 2023

Hyperthermia as a Potential Cornerstone of Effective Multimodality Treatment with Radiotherapy, Cisplatin and PARP Inhibitor in IDH1-Mutated Cancer Cells.

Hyperthermia as a Potential Cornerstone of Effective Multimodality Treatment with Radiotherapy, Cisplatin and PARP Inhibitor in IDH1-Mutated Cancer Cells.

Journal: Cancers
Published: October 30, 2022

Radio-sensitizing effect of MEK inhibition in glioblastoma in vitro and in vivo.

Radio-sensitizing effect of MEK inhibition in glioblastoma in vitro and in vivo.

Journal: Journal of cancer research and clinical oncology
Published: October 18, 2022

Radiobiological Aspects of FLASH Radiotherapy.

Radiobiological Aspects of FLASH Radiotherapy.

Journal: Biomolecules
Published: July 21, 2022

Biodegradable Ultrasmall-in-Nano Architectures Loaded with Cisplatin Prodrug in Combination with Ionizing Radiation Induces DNA Damage and Apoptosis in Pancreatic Ductal Adenocarcinoma.

Biodegradable Ultrasmall-in-Nano Architectures Loaded with Cisplatin Prodrug in Combination with Ionizing Radiation Induces DNA Damage and Apoptosis in Pancreatic Ductal Adenocarcinoma.

Journal: Cancers
Published: May 23, 2022

WEE1 kinase inhibitor MK-1775 sensitizes oral tongue squamous cell carcinoma cells to radiation irrespective of TP53 status.

WEE1 kinase inhibitor MK-1775 sensitizes oral tongue squamous cell carcinoma cells to radiation irrespective of TP53 status.

Journal: Oral diseases
Published: January 07, 2022

Tumor grafted - chick chorioallantoic membrane as an alternative model for biological cancer research and conventional/nanomaterial-based theranostics evaluation.

Tumor grafted - chick chorioallantoic membrane as an alternative model for biological cancer research and conventional/nanomaterial-based theranostics evaluation.

Journal: Expert opinion on drug metabolism & toxicology
Published: February 10, 2021

Experimental and clinical studies on radiation and curcumin in human glioma.

Experimental and clinical studies on radiation and curcumin in human glioma.

Journal: Journal of cancer research and clinical oncology
Published: May 15, 2020

Pancreatic cancer resistance conferred by stellate cells: looking for new preclinical models.

Pancreatic cancer resistance conferred by stellate cells: looking for new preclinical models.

Journal: Experimental hematology & oncology
Published: May 15, 2020

Comment on: Targeting the HGF/c-MET pathway in advanced pancreatic cancer: a key element of treatment that limits primary tumour growth and eliminates metastasis.

Comment on: Targeting the HGF/c-MET pathway in advanced pancreatic cancer: a key element of treatment that limits primary tumour growth and eliminates metastasis.

Journal: British journal of cancer
Published: April 25, 2020

Preclinical evaluation of binimetinib (MEK162) delivered via polymeric nanocarriers in combination with radiation and temozolomide in glioma.

Preclinical evaluation of binimetinib (MEK162) delivered via polymeric nanocarriers in combination with radiation and temozolomide in glioma.

Journal: Journal of neuro-oncology
Published: October 30, 2019
Showing 1-12 of 30

Last Updated: 09/26/2026